Lexaria Forms New Scientific Advisory Board
North American drug delivery development experts added to help guide Lexaria's strategic plans KELOWNA, BC / ACCESSWIRE / December 18,...
Brain
BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions
Collaboration will leverage BioAge's differentiated human longevity data and platform and Novartis expertise in the biology of physical exercise to...
Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome
Dravet syndrome is a genetic developmental and epileptic encephalopathy (DEE) often caused by a mutation in SCN1A This is the...
Cognition Therapeutics Announces Positive Results in Phase 2 Study of CT1812 in Dementia with Lewy Bodies
- Improvements Across Measures of Behavior, Function, Cognition and Movement - - Expediting Plans to Advance CT1812 into Late-Stage Trials...
Vandria announces first subjects dosed in its first-in-human Phase 1 clinical trial of VNA-318 brain-penetrant mitophagy inducer
LAUSANNE, Switzerland, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Vandria SA, a company at the vanguard of mitochondrial therapeutics developing first-in-class...
ISS National Lab-Sponsored Projects on Cancer, Neurodegenerative Conditions, and More Return From Space Station
Nearly 50 payloads safely splashed down to Earth on SpaceX's 31st Commercial Resupply Services Mission for NASA KENNEDY SPACE CENTER, Fla.,...
CLR Neurosthenics® launches neurophysiological assessment platform to help prevent sports injuries, optimize performance and improve rehabilitation
LOS ANGELES, Dec. 17, 2024 /PRNewswire/ -- Sports and recreational injuries send more than 3.5 million Americans to the hospital...
BRAIN.ONE Brain Fitness Platform Announces Strategic Partnership with Acclaimed Thought Leader Tim Storey and Global Recovery Advocate Darren Prince
ASPEN, Colo., Dec. 17, 2024 /PRNewswire/ -- BRAIN.ONE, a groundbreaking personalized brain fitness platform, is pleased to announce a partnership...
Neuvotion Expands Partnership with Intelligent Product Solutions and Commercializes NeuStim™ Technology for Stroke and Spinal Cord Injury
STAMFORD, Conn., Dec. 17, 2024 /PRNewswire/ -- Neuvotion, Inc. is an early-stage medical device company developing AI-driven neuromodulation technologies and products...
Large Clinical Study Finds Home-based Virtual Reality Device Creates Greater Relief for High Impact Chronic Pain Patients
Secondary analysis of a randomized, placebo-controlled study of 1,000+ participants indicated that FDA-authorized RelieVRx® yielded clinically meaningful pain intensity and pain...
Lt. Col. Scott Flurry’s Final Mission
A 1,100-Mile Journey Across Borders to Save Lives Through Organ DonationNote: A video accompanying this press release shares Scott's inspiring...
Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience
Dr. Gibson joining Lexaria's new scientific advisor board KELOWNA, BC / ACCESSWIRE / December 17, 2024 / Lexaria Bioscience Corp....
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets
Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.GUILFORD,...
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets
Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.GUILFORD,...
Vaccinex Announces Receipt of Delisting Notification from Nasdaq
ROCHESTER, N.Y., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company...
NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025
Company’s Exclusive Distribution Agreement with Zimmer Biomet included $3.0 Million Upfront Payment: Expected to Drive Revenue and Expand Margins Significantly...
Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review...
Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium
Single intrathecal dose of Rhenium (186Re) Obisbemeda delivers favorable responses in cerebrospinal fluid circulating tumor cell count, imaging, and clinical...
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology...
Exploring Space and Neurotherapeutics at the 2025 Ultrasound Event: A Journey into the Future of Medical Ultrasound
ORLANDO, Fla., Dec. 16, 2024 /PRNewswire/ -- The 2025 AIUM Annual Convention, hosted by the American Institute of Ultrasound in...